TGA Approval

REPATHA evolocumab (rch) 140 mg/mL injection solution syringe (231151)

ARTG ID

231151

ARTG Name

REPATHA evolocumab (rch) 140 mg/mL injection solution syringe

Sponsor

Amgen Australia Pty Ltd

ARTG Date

December 9, 2015

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/de0e5ab92a5811514383dae8f0f63a34.pdf

Ingredient Name

evolocumab

Empowering clinical research with data-driven insights and AI-powered tools.

REPATHA evolocumab (rch) 140 mg/mL injection solution syringe (231151) - TGA 批准文号 | MedPath